CURALEAF INTERNATIONAL LIMITED
Get an alert when CURALEAF INTERNATIONAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£5.1m
+77.4% vs 2024
Net assets
-£34m
+13.8% vs 2024
Employees
446
+26.7% highest in 3 filed years
Profit before tax
£2.6m
+118.1% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Negative shareholders' funds
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £28,825,000 | £49,345,000 | £68,339,000 | +38.5% | |
| Operating profit | -£11,621,000 | -£5,380,000 | £843,000 | +115.7% | |
| Profit before tax | -£11,565,000 | -£14,326,000 | £2,597,000 | +118.1% | |
| Net profit | -£11,687,000 | — | £3,526,000 | — | |
| Cash | £6,969,000 | £2,846,000 | £5,050,000 | +77.4% | |
| Total assets less current liabilities | -£15,964,000 | £815,000 | £19,244,000 | +2,261.2% | |
| Net assets | -£26,119,000 | -£39,258,000 | -£33,838,000 | +13.8% | |
| Equity | -£26,119,000 | -£39,258,000 | -£33,838,000 | +13.8% | |
| Average employees | 313 | 352 | 446 | +26.7% | |
| Wages | £13,165,000 | £15,012,000 | £19,939,000 | +32.8% | |
| Directors' remuneration | £838,000 | £671,000 | £847,000 | +26.2% | |
| Directors' pension contributions | — | £10,000 | £14,000 | +40% | |
| Highest paid director | £342,000 | £358,000 | £430,000 | +20.1% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | -40.3% | -10.9% | 1.2% | |
| Net margin | -40.5% | — | 5.2% | |
| Return on capital employed | — | -660.1% | 4.4% | |
| Gearing (liabilities / total assets) | 130.0% | 143.2% | 130.3% | |
| Current ratio | 0.32x | 0.37x | 0.54x | |
| Interest cover | -2.33x | -0.76x | 0.11x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- CURALEAF INTERNATIONAL LIMITED 2021-10-20 → present
- EMMAC LIFE SCIENCES LIMITED 2018-03-14 → 2021-10-20
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- PKF Littlejohn LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors assess whether the use of going concern is appropriate i.e. whether there are any material uncertainties... The company is reliant on the ongoing support of its ultimate parent company Curaleaf Holdings, Inc.”
Group structure
- CURALEAF INTERNATIONAL LIMITED · parent
- Curaleaf UK Limited 100%
- EMMAC Malta Limited 100%
- EMMAC Life Sciences Espana, SL 100%
- Curaleaf Portugal Lda 100%
- Curaleaf II Portugal Lda 100%
- Curaleaf Suisse SARL 100%
- Medalchemy S.L. 97.5%
- Rokshaw Limited 100%
- Curaleaf Deutschland (GmbH) 100%
- Adven GmbH 100%
- Curaleaf International Pharma SARL 100%
- Curaleaf International Poland Spótka Z.O.O. 100%
- Curaleaf Poland S.A. 100%
- Curaleaf International Tarim Sanayi Ve Ticaret Anonim Sirket 100%
- Curaleaf France SAS 100%
- Sapphire Medical Clinics Limited 100%
- Sapphire Clinics (London) Limited 100%
- Sapphire Clinics (Central) Limited 100%
- Mediras Deutschland GmbH 100%
- Centrum Medyczne Curaleaf sp. z o.o. 100%
- Curaleaf International (Australia) Pty Ltd 100%
Significant events
- “In April 2025 the Group completed the acquisition of Centrum Medyczne Curaleaf sp. z o.o., a medical cannabis clinic operating from 15 sites in Poland.”
- “During April 2025, £0.7m was paid in settlement of the deferred consideration liability, of which £0.1m was settled through the issuance of shares in Curaleaf Holdings, Inc.”
- “On 15 December 2023, the Group decided to dispose of the non-cannabis unlicensed medicines ('Specials') business and the sale was completed on 29 April 2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GRUZDEV, Ilia | Director | 2025-11-28 | Dec 1983 | British |
| MARTINEZ, Juan Pablo | Director | 2023-12-19 | Aug 1993 | Spanish |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ABONY, Lorne | Director | 2019-10-18 | 2021-04-07 |
| COSTANZO, Antonio Filippo Augusto | Director | 2018-09-20 | 2022-12-31 |
| DOONA, Peter Charles Michael | Director | 2022-07-13 | 2025-11-28 |
| ELLEN, Thomas George | Director | 2019-02-06 | 2022-07-13 |
| MCDERMOTT, Edward Peter | Director | 2018-03-14 | 2021-06-30 |
| PACCHETTI, Barbara | Director | 2019-05-01 | 2022-12-22 |
| ROOKE, Thomas Philip Kirshaw | Director | 2018-10-16 | 2023-02-21 |
| WORNE, Miles Dymoke | Director | 2022-07-13 | 2023-12-01 |
| YARKONI, Orr, Dr | Director | 2019-07-12 | 2021-04-07 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Boris Alexis Jordan | Individual | Voting 50–75%, Appoints directors | 2021-04-07 | Active |
| Mr Edward Peter Mcdermott | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-03-14 | Ceased 2018-09-20 |
Filing timeline
Last 20 of 63 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-09-26 | AA | accounts | Accounts with accounts type group | |
| 2026-06-19 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-12-02 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-02 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-06 | AA | accounts | Accounts with accounts type group | |
| 2025-09-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-10 | AA | accounts | Accounts with accounts type group | |
| 2024-10-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-12-22 | AP01 | officers | Appoint person director company with name date | |
| 2023-12-22 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-11 | AA | accounts | Accounts with accounts type group | |
| 2023-09-21 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-02-21 | TM01 | officers | Termination director company with name termination date | |
| 2023-01-03 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-22 | TM01 | officers | Termination director company with name termination date | |
| 2022-10-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-08 | AP01 | officers | Appoint person director company with name date | |
| 2022-08-08 | AP01 | officers | Appoint person director company with name date | |
| 2022-08-08 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.